Task Force 11: Additional Cardiac Conditions and Considerations in Competitive Athletes

The recently updated AHA/ACC Scientific Statement: Clinical Considerations for Competitive Sports Participation for Athletes with Cardiovascular Abnormalities provides a comprehensive framework for guiding clinicians in the evaluation and management of competitive athletes. Divided into 11 Task Forces, it covers a broad range of cardiovascular diseases and clinical scenarios. Task Force 11 was devoted to cardiac conditions and considerations in athletes not included in the other Task Forces. Here, we present the detailed rationale for the clinical considerations covered in this section of the Scientific Statement. These topics include hypertension, commotio cordis, pulmonary embolism, performance-enhancing drugs and supplements, exercise in extreme environments (specifically altitude and scuba diving), and pregnancy.

Authors

Institutions

Publication Details

Journal
Medicine & Science in Sports & Exercise
Published
2026-11-13
DOI
https://doi.org/10.1249/mss.0000000000004099
Primary Topic
Cardiovascular Effects of Exercise
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Task Force 11: Additional Cardiac Conditions and Considerations in Competitive Athletes

Jonathan H. Kim, Katherine Elena Economy, Michael Scott Emery, Jeffrey J. Hsu et al.
5 links
Medicine & Science in Sports & Exercise
Cardiovascular Effects of Exercise
article

Task Force 11: Additional Cardiac Conditions and Considerations in Competitive Athletes

Jonathan H. Kim, Katherine Elena Economy, Michael Scott Emery, Jeffrey J. Hsu, Aaron Leigh Baggish, Mark S. Link, Tamanna Singh, BENJAMIN D. LEVINE, ANDRE LAGERCHE, KATIE M. STEWART
article en

Abstract

The recently updated AHA/ACC Scientific Statement: Clinical Considerations for Competitive Sports Participation for Athletes with Cardiovascular Abnormalities provides a comprehensive framework for guiding clinicians in the evaluation and management of competitive athletes. Divided into 11 Task Forces, it covers a broad range of cardiovascular diseases and clinical scenarios. Task Force 11 was devoted to cardiac conditions and considerations in athletes not included in the other Task Forces. Here, we present the detailed rationale for the clinical considerations covered in this section of the Scientific Statement. These topics include hypertension, commotio cordis, pulmonary embolism, performance-enhancing drugs and supplements, exercise in extreme environments (specifically altitude and scuba diving), and pregnancy.

Medicine & Science in Sports & ExerciseVol. 58(12)
Brigham and Women's Hospital (US), Harvard University (US), Emory University (US), University of California, Los Angeles (US), Victor Chang Cardiac Research Institute (AU), Texas Health Dallas (US), Centre Hospitalier Universitaire Vaudois (CH), Cleveland Clinic Lerner College of Medicine (US), St Vincent's Hospital Melbourne (AU), Massachusetts General Hospital (US), Institute for Exercise and Environmental Medicine (US), VA Greater Los Angeles Healthcare System (US), Case Western Reserve University (US), The University of Texas Southwestern Medical Center (US)
Good health and well-being
Cardiovascular Effects of Exercise
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon